IL286704A - Probiotic biofilm compositions and methods of preparing same - Google Patents
Probiotic biofilm compositions and methods of preparing sameInfo
- Publication number
- IL286704A IL286704A IL286704A IL28670421A IL286704A IL 286704 A IL286704 A IL 286704A IL 286704 A IL286704 A IL 286704A IL 28670421 A IL28670421 A IL 28670421A IL 286704 A IL286704 A IL 286704A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- preparing same
- biofilm compositions
- probiotic biofilm
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/368,030 US10709744B1 (en) | 2019-03-28 | 2019-03-28 | Probiotic biofilm suppositories |
| US201962827931P | 2019-04-02 | 2019-04-02 | |
| PCT/IL2020/050380 WO2020194319A1 (en) | 2019-03-28 | 2020-03-29 | Probiotic biofilm compositions and methods of preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL286704A true IL286704A (en) | 2021-10-31 |
Family
ID=72610340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL286704A IL286704A (en) | 2019-03-28 | 2021-09-26 | Probiotic biofilm compositions and methods of preparing same |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3946392A4 (en) |
| JP (1) | JP2022535323A (en) |
| KR (1) | KR20220016042A (en) |
| CN (1) | CN113766923A (en) |
| AU (1) | AU2020250170A1 (en) |
| BR (1) | BR112021019437A2 (en) |
| CA (1) | CA3131165A1 (en) |
| IL (1) | IL286704A (en) |
| MX (1) | MX2021011628A (en) |
| SG (1) | SG11202110741YA (en) |
| WO (1) | WO2020194319A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023195008A1 (en) * | 2022-04-05 | 2023-10-12 | Mybiotics Pharma Ltd. | Bacterial compositions and methods for growing bacteria on particles |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
| WO2009092810A2 (en) * | 2008-01-24 | 2009-07-30 | Bacterfield Oü | Single pharmaceutical composition containing antibiotics and probiotics |
| EP2512266A4 (en) * | 2008-11-14 | 2013-12-18 | Unistraw Holdings Pte Ltd | Probiotic compositions, methods and apparatus for their administration |
| IT1400821B1 (en) * | 2009-03-09 | 2013-07-02 | Probiotical Spa | OIL SUSPENSION CONTAINING PROBIOTIC BACTERIA FOR PEDIATRIC USE |
| ITMI20120131A1 (en) * | 2012-02-01 | 2013-08-02 | Probiotical Spa | MULTILAYER MICROCAPSULATED PROBIOTIC BACTERIA, THEIR PRODUCTION AND USE |
| CA2941694A1 (en) * | 2014-03-06 | 2015-09-11 | Research Institute At Nationwide Children's Hospital | Probiotic formulations and methods for use |
| ES2680471T3 (en) * | 2014-03-28 | 2018-09-07 | Dsm Ip Assets B.V. | Procedure to isolate a carotenoid from a carotenoid-producing bioorganism |
| JP6990922B2 (en) * | 2015-05-11 | 2022-01-12 | マイバイオティクス ファーマ リミテッド | Systems and methods for growing live bacterial biofilms on solid particles for bacterial colonization in the intestine |
| EP3373908B8 (en) * | 2015-11-10 | 2025-12-03 | ProbioTech USA LLC | Probiotic delivery systems |
| JP7357326B2 (en) * | 2015-11-30 | 2023-10-06 | イマジリン テクノロジー エルエルシー | Compositions containing probiotics and methods of use thereof |
| KR101784847B1 (en) * | 2016-05-10 | 2017-10-13 | 주식회사 하우동천 | A composition comprising lactic acid bacteria for protecting and treating vaginosis disease and the use thereof |
| IL263218B (en) * | 2016-05-25 | 2022-07-01 | Mybiotics Pharma Ltd | Compounds and methods for microbiotic therapy |
| EP3462917B1 (en) * | 2016-05-29 | 2024-10-30 | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) | Method of generating bacterial compositions |
| WO2018013583A2 (en) * | 2016-07-11 | 2018-01-18 | The Brigham And Women's Hospital, Inc. | Medicinal vaginal lactobacillus cocktail |
| EP3388069B1 (en) * | 2017-04-12 | 2019-05-01 | ETH Zurich | Consortia of living bacteria useful for treatment of microbiome dysbiosis |
| US20190209626A1 (en) * | 2018-01-05 | 2019-07-11 | Human Longevity, Inc. | Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla |
-
2020
- 2020-03-29 WO PCT/IL2020/050380 patent/WO2020194319A1/en not_active Ceased
- 2020-03-29 JP JP2021558510A patent/JP2022535323A/en active Pending
- 2020-03-29 CN CN202080031956.1A patent/CN113766923A/en active Pending
- 2020-03-29 CA CA3131165A patent/CA3131165A1/en active Pending
- 2020-03-29 EP EP20776481.2A patent/EP3946392A4/en not_active Withdrawn
- 2020-03-29 AU AU2020250170A patent/AU2020250170A1/en not_active Abandoned
- 2020-03-29 SG SG11202110741YA patent/SG11202110741YA/en unknown
- 2020-03-29 BR BR112021019437A patent/BR112021019437A2/en not_active Application Discontinuation
- 2020-03-29 MX MX2021011628A patent/MX2021011628A/en unknown
- 2020-03-29 KR KR1020217034591A patent/KR20220016042A/en not_active Withdrawn
-
2021
- 2021-09-26 IL IL286704A patent/IL286704A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020250170A1 (en) | 2021-10-28 |
| KR20220016042A (en) | 2022-02-08 |
| EP3946392A1 (en) | 2022-02-09 |
| CA3131165A1 (en) | 2020-10-01 |
| BR112021019437A2 (en) | 2021-11-30 |
| SG11202110741YA (en) | 2021-10-28 |
| WO2020194319A1 (en) | 2020-10-01 |
| EP3946392A4 (en) | 2022-12-07 |
| MX2021011628A (en) | 2021-12-10 |
| CN113766923A (en) | 2021-12-07 |
| JP2022535323A (en) | 2022-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277889A (en) | Oligonucleotide compositions and methods of use thereof | |
| IL274276A (en) | Casz compositions and methods of use | |
| SG11202010131QA (en) | Oligonucleotide compositions and methods of use thereof | |
| GB2582100B (en) | CAS12C Compositions and methods of use | |
| ZA201906169B (en) | Synthekine compositions and methods of use | |
| IL276135A (en) | Compositions and methods of use | |
| SG11202011274YA (en) | Chemical compositions and methods of using same | |
| ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
| SG11202106585UA (en) | Polishing compositions and methods of using same | |
| ZA202004531B (en) | Compositions containing thymohydroquinone and their method of preparation | |
| GB202105087D0 (en) | Microbial compositions and methods of use | |
| EP4081231A4 (en) | Compositions comprising microbes and methods of use and making thereof | |
| EP3606493A4 (en) | Dental cement compositions and methods of use | |
| SG11202106584QA (en) | Polishing compositions and methods of using same | |
| IL287797A (en) | Oligosaccharide compositions and methods of use | |
| GB202319843D0 (en) | CAS13-based compositions and methods of use thereof | |
| GB201905386D0 (en) | Probiotic compositions and uses thereof | |
| IL286704A (en) | Probiotic biofilm compositions and methods of preparing same | |
| SG11202002351SA (en) | Poloxamer compositions and methods of making and using same | |
| IL288495A (en) | Compositions and methods of making ribitol | |
| GB201919385D0 (en) | Compositions and methods of manufacture | |
| IL268303A (en) | Compositions and methods comprising co-culture of hepatocytes | |
| IL311518A (en) | Prekallikrein-modulating compositions and methods of use thereof | |
| IL289073A (en) | Dichlorphenamide compositions and methods of use | |
| IL291538A (en) | Anti-aging compositions and methods of use thereof |